Neil Stahl Selected Research

Neil Stahl Research Topics

Disease

11	Asthma (Bronchial Asthma) 01/2021 - 06/2013
10	COVID-19 10/2022 - 01/2020
10	Infections 01/2022 - 03/2012
10	Atopic Dermatitis (Atopic Eczema) 01/2020 - 07/2014
8	Injection Site Reaction 01/2020 - 08/2008
8	Inflammation (Inflammations) 01/2020 - 06/2013
5	Eczema 01/2020 - 07/2014
5	Macular Degeneration (Age-Related Maculopathy) 01/2016 - 06/2011
4	Nasopharyngitis 02/2016 - 06/2013
3	Sinusitis 01/2020 - 01/2016
3	Conjunctivitis 01/2020 - 12/2016
3	Nasal Polyps (Nasal Polyp) 11/2019 - 01/2016
3	Headache (Headaches) 02/2016 - 06/2013
3	Rheumatoid Arthritis 06/2015 - 12/2009
2	Asymptomatic Infections 09/2021 - 01/2021
2	Pain (Aches) 01/2021 - 11/2019
2	Eosinophilia 01/2018 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 12/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 12/2015
2	Pruritus (Itching) 12/2016 - 07/2014
2	Neoplasms (Cancer) 01/2016 - 11/2007
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2015 - 03/2012
2	Macular Edema 10/2015 - 11/2014
2	Neutropenia 06/2015 - 09/2014
2	Gout 03/2012 - 12/2009
2	Cryopyrin-Associated Periodic Syndromes 12/2009 - 08/2008
1	Pneumonia (Pneumonitis) 01/2022
1	Low Back Pain (Lumbago) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Allergic Rhinitis 01/2021
1	Eosinophilic Esophagitis 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Airway Remodeling 12/2019
1	Polyps 11/2019
1	Rhinosinusitis 11/2019
1	Joint Diseases (Joint Disease) 11/2019
1	Osteoarthritis 11/2019
1	Ebola Hemorrhagic Fever 11/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2016
1	Kidney Neoplasms (Kidney Cancer) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016

Drug/Important Bio-Agent (IBA)

20	Monoclonal AntibodiesIBA 10/2022 - 03/2012
14	dupilumabIBA 01/2020 - 06/2013
9	casirivimab and imdevimab drug combinationIBA 10/2022 - 11/2020
8	Interleukin-13IBA 01/2020 - 07/2014
8	afliberceptIBA 01/2016 - 11/2007
7	Interleukin-4 (Interleukin 4)IBA 01/2020 - 07/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2007
4	AntibodiesIBA 01/2022 - 07/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2015
4	Neutralizing AntibodiesIBA 01/2021 - 07/2015
4	CytokinesIBA 01/2020 - 01/2016
4	Pharmaceutical PreparationsIBA 11/2019 - 06/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 02/2016
3	AllergensIBA 01/2021 - 01/2020
3	InterleukinsIBA 11/2019 - 01/2016
3	GlucocorticoidsIBA 01/2018 - 06/2013
3	sarilumabIBA 06/2015 - 09/2014
3	Biomarkers (Surrogate Marker)IBA 07/2014 - 11/2007
3	rilonacept FDA Link 03/2012 - 08/2008
3	Interleukin-1 (Interleukin 1)IBA 03/2012 - 08/2008
2	fasinumabIBA 01/2021 - 11/2019
2	Immunoglobulin A (IgA)IBA 01/2020 - 10/2017
2	LipidsIBA 01/2017 - 09/2014
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2016 - 06/2013
2	Ranibizumab (Lucentis)FDA Link 01/2016 - 12/2012
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2015 - 09/2014
2	Methotrexate (Mexate)FDA LinkGeneric 06/2015 - 09/2014
1	COVID-19 VaccinesIBA 10/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 09/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	ChemokinesIBA 01/2020
1	Interleukin-33IBA 12/2019
1	Analgesics (Analgesic Drugs)IBA 11/2019
1	Prostaglandins AIBA 11/2019
1	Nerve Growth Factor (NGF)IBA 11/2019
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	PlacebosIBA 01/2018
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 02/2016
1	Nasal SpraysIBA 02/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	pegaptanib (Macugen)FDA Link 01/2016
1	alirocumabIBA 12/2015
1	oxidized low density lipoproteinIBA 12/2015

Therapy/Procedure

8	Therapeutics 11/2020 - 03/2012
2	Lasers (Laser) 10/2015 - 11/2014
1	Subcutaneous Injections 01/2021
1	Intranasal Administration 01/2020
1	Aftercare (After-Treatment) 01/2016